TF–FVIIa–driven PAR2 activation triggers EV generation from human TNBC cells, which promotes EMT in non–metastatic breast cancer cells, leading to the induction of proliferation, migration, invasion, and anti–apoptosis
TF–FVIIa–driven PAR2 activation triggers EV generation from human TNBC cells, which promotes EMT in non–metastatic breast cancer cells, leading to the induction of proliferation, migration, invasion, and anti–apoptosis. TF–FVIIa–mediated cleavage of PAR2 in human TNBC cells leads to the intracellular activation of AKT, ROCK, and ERK1/2 pathways independently, which promotes the release of EVs packaged with miR–221 via actomyosin reorganization. TNBC–EVs are taken up by non–metastatic breast cancer cells, thereby delivering miR–221 into the recipient cells. In recipient cells, miR–221 targets PTEN, leading to the activation of AKT/p65–signaling pathway in which the activated (via phosphorylation) p65 enters the nucleus to stimulate the upregulation of N–cadherin and vimentin while downregulating the expression of E–cadherin. As a result of this, EMT is induced, which ultimately leads to the promotion of proliferation, migration, invasion, and anti–apoptosis of EV–fused recipient cells. Red arrows indicate decreased and green arrow indicate increased levels.
Publication
Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential (2023) Kaushik Das, et al. Cancers (Basel). 2023 Oct;15(19). Figure: F5.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | PAR2 | PAR2 | ncbigene_synonym | F2RL1 | 2150 |
| Homo sapiens | Primates | PAR2 | PAR2 | ncbigene_synonym | NR1I2 | 8856 |
| Homo sapiens | Primates | PAR2 | PAR2 | ncbigene_synonym | SLC52A1 | 55065 |
| Homo sapiens | Primates | ERK1 | ERK1 | ncbigene_synonym | MAPK3 | 5595 |
| Homo sapiens | Primates | ERK1/2 | ERK2 | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | ROCK | ROCK | famplex_relations | ROCK1 | 6093 |
| Homo sapiens | Primates | ROCK | ROCK | famplex_relations | ROCK2 | 9475 |
| Homo sapiens | Primates | miR-221 | MIR-221 | ncbigene_synonym | MIR221 | 407006 |
| Homo sapiens | Primates | E-cadherin↓ | CDH1 | ncbigene_symbol | CDH1 | 999 |
| Homo sapiens | Primates | E-cadherin↓ | CDH1 | ncbigene_synonym | FZR1 | 51343 |
| Homo sapiens | Primates | P65 | P65 | ncbigene_synonym | RELA | 5970 |
| Homo sapiens | Primates | P65 | P65 | ncbigene_synonym | SYT1 | 6857 |
| Homo sapiens | Primates | P65 | P65 | ncbigene_synonym | GORASP1 | 64689 |
| Homo sapiens | Primates | P65 | P65 | ncbigene_synonym | WNK1 | 65125 |
| Homo sapiens | Primates | N-cadherin | CDH2 | ncbigene_symbol | CDH2 | 1000 |
| Homo sapiens | Primates | EMT | EMT | ncbigene_synonym | ITK | 3702 |
| Homo sapiens | Primates | EMT | EMT | ncbigene_synonym | SLC22A3 | 6581 |
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Nucleus | nucleus | nucleus | chebi:33252 | |
| Nucleus | nucleus | nucleus | chebi:33252 |